Yayın:
Use of complementary and alternative medicine in children with cancer: Effect on survival

dc.contributor.buuauthorKaralı, Yasin
dc.contributor.buuauthorDemirkaya, Metin
dc.contributor.buuauthorSevinir, Betül
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPediatri Ana Bilim Dalı
dc.contributor.orcid0000-0003-0710-5422
dc.contributor.researcheridC-7392-2019
dc.contributor.researcheridAAH-1570-2021
dc.contributor.scopusid49863694000
dc.contributor.scopusid24331130000
dc.contributor.scopusid6603199915
dc.date.accessioned2022-04-13T13:40:20Z
dc.date.available2022-04-13T13:40:20Z
dc.date.issued2012-05
dc.description.abstractThe objective of the present study was to determine the type, frequency, the reason why complementary and alternative medicine (CAM) treatments are used, the factors related with their use, and the effects of CAM usage on long-term survival. Families of a total of 120 children with cancer between 0-18 years of age, including 50 (41.7%) girls and 70 (58.3%) boys, participated in our study. The authors found that 88 patients (73.3%) used at least one CAM method, the most common (95.5%) of which was biologically based therapies. Most frequently used biologically based therapies were dietary supplements and herbal products. The most commonly used dietary supplement or herbal product was honey (43.2%) or stinging nettle (43.2%), respectively. We found that patients used such CAM methods as complementary to, but not instead of, conventional therapy. Sixty-nine out of 88 patient families (78.4%) shared the CAM method they used with their physicians. No statistically significant relation was found between socioeconomic, sociodemographic, or other factors or items and CAM use. The mean follow-up period of the CAM users and nonusers groups was 79.4 +/- 36.7 (21.3-217.9) and 90.9 +/- 50.3 (27.4-193.7) months, respectively. Five-year survival rates for CAM users and nonusers were found as 81.5% and 86.5%, respectively (P > .05). In conclusion, families of children with cancer use complementary and alternative treatment frequently. They do not attempt to replace conventional treatment with CAM. Higher rates of CAM use was found in families with higher educational level. CAM usage did not affect the long-term survival.
dc.identifier.citationKaralı, Y. vd. (2012). "Use of complementary and alternative medicine in children with cancer: Effect on survival". Pediatric Hematology and Oncology, 29(4), 335-344.
dc.identifier.doi10.3109/08880018.2012.670368
dc.identifier.endpage344
dc.identifier.issn0888-0018
dc.identifier.issue4
dc.identifier.pubmed22568796
dc.identifier.scopus2-s2.0-84860850481
dc.identifier.startpage335
dc.identifier.urihttps://doi.org/10.3109/08880018.2012.670368
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.3109/08880018.2012.670368
dc.identifier.urihttp://hdl.handle.net/11452/25764
dc.identifier.volume29
dc.identifier.wos000303832800005
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.journalPediatric Hematology and Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectHematology
dc.subjectPediatrics
dc.subjectAlternative treatment
dc.subjectCancer
dc.subjectChildren
dc.subjectComplementary medicine
dc.subjectPediatric oncology patients
dc.subjectTherapies
dc.subjectTurkey
dc.subject.emtreeAdolescent
dc.subject.emtreeAdult
dc.subject.emtreeAlternative medicine
dc.subject.emtreeArticle
dc.subject.emtreeCancer survival
dc.subject.emtreeChild
dc.subject.emtreeDemography
dc.subject.emtreeDiet supplementation
dc.subject.emtreeEducation
dc.subject.emtreeFamily
dc.subject.emtreeFemale
dc.subject.emtreeFollow up
dc.subject.emtreeHodgkin disease
dc.subject.emtreeHoney
dc.subject.emtreeHuman
dc.subject.emtreeInfant
dc.subject.emtreeLong term survival
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeNephroblastoma
dc.subject.emtreeNeuroblastoma
dc.subject.emtreeNewborn
dc.subject.emtreeNonhodgkin lymphoma
dc.subject.emtreeOsteosarcoma
dc.subject.emtreePhysician
dc.subject.emtreePreschool child
dc.subject.emtreeSchool child
dc.subject.emtreeSocioeconomics
dc.subject.emtreeSoft tissue sarcoma
dc.subject.emtreeSurvival rate
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshComplementary therapies
dc.subject.meshDietary supplements
dc.subject.meshDisease-free survival
dc.subject.meshFemale
dc.subject.meshFollow-up studies
dc.subject.meshHoney
dc.subject.meshAdolescent
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshInfant, newborn
dc.subject.meshMale
dc.subject.meshNeoplasms
dc.subject.meshPlants, medicinal
dc.subject.meshSurvival rate
dc.subject.meshUrtica dioica
dc.subject.scopusComplementary and Alternative Medicine; Homeopathy; Acupuncture
dc.subject.wosOncology
dc.subject.wosHematology
dc.subject.wosPediatrics
dc.titleUse of complementary and alternative medicine in children with cancer: Effect on survival
dc.typeArticle
dc.wos.quartileQ3 (Pediatrics)
dc.wos.quartileQ4
dc.wos.quartileQ3
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Pediatri Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama